Global Site License: US$ 875.00
Introduction
This databook provides key data and information on the Analgesics Market in Vietnam (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
The analgesics category was valued at VND431,920.4m ($26.5m) in 2009, representing a CAGR of 7.7% since 2004.
By the end of 2014, the analgesics category will be worth VND568,303.3m ($34.9m), with an expected CAGR of 5.6% between 2009 and 2014.
The analgesics market was led by paracetamol (representing 33.9% of the total value) followed by ibuprofen and aspirin, with a 30.3% and 22.4% market share, respectively. Other analgesics accounts for the remaining 13.4% share.
Johnson & Johnson is the market leader with a 16.2% share of the market.
Reasons to Purchase
Introduction
This databook provides key data and information on the Analgesics Market in Vietnam (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
The analgesics category was valued at VND431,920.4m ($26.5m) in 2009, representing a CAGR of 7.7% since 2004.
By the end of 2014, the analgesics category will be worth VND568,303.3m ($34.9m), with an expected CAGR of 5.6% between 2009 and 2014.
The analgesics market was led by paracetamol (representing 33.9% of the total value) followed by ibuprofen and aspirin, with a 30.3% and 22.4% market share, respectively. Other analgesics accounts for the remaining 13.4% share.
Johnson & Johnson is the market leader with a 16.2% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Analgesics Market in Vietnam (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements
CHAPTER 1 EXECUTIVE SUMMARY
Summary category level: analgesics
CHAPTER 2 DEFINITION
CHAPTER 3 CATEGORY ANALYSIS: ANALGESICS
Value analysis (Vietnamese Dong), 2004−09
Value analysis (Vietnamese Dong), 2009−14
Value analysis (US dollars), 2004−09
Value analysis (US dollars), 2009−14
Company and brand share analysis
Distribution analysis
CHAPTER 4 MACROECONOMIC PROFILE
Macroeconomic Indicators
CHAPTER 5 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Analgesics, Vietnam, value by segment (VNDm), 2004−14
Figure 2: Analgesics, Vietnam, category growth comparison, by value, 2004−14
Figure 3: Analgesics, Vietnam, company share by value (%), 2008−09
Figure 4: Analgesics, Vietnam, distribution channels by value (%), 2008−09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Analgesics category definitions
Table 2: Analgesics distribution channels
Table 3: Analgesics, Vietnam, value by segment (VNDm), 2004−09
Table 4: Analgesics, Vietnam, value forecast by segment (VNDm), 2009−14
Table 5: Analgesics, Vietnam, value by segment ($m), 2004−09
Table 6: Analgesics, Vietnam, value forecast by segment ($m), 2009−14
Table 7: Analgesics, Vietnam, brand share by value (%), 2008−09
Table 8: Analgesics, Vietnam, value by brand (VNDm), 2008−09
Table 9: Analgesics, Vietnam, company share by value (%), 2008−09
Table 10: Analgesics, Vietnam, value by company (VNDm), 2008−09
Table 11: Analgesics, Vietnam, distribution channels by value (%), 2008−09
Table 12: Analgesics, Vietnam, value by distribution channel (VNDm), 2008−09
Table 13: Vietnam population, by age group, 2004−09 (millions)
Table 14: Vietnam population forecast, by age group, 2009−14 (millions)
Table 15: Vietnam population, by gender, 2004−09 (millions)
Table 16: Vietnam population forecast, by gender, 2009−14 (millions)
Table 17: Vietnam nominal GDP, 2004−09 (VNDbn, nominal prices)
Table 18: Vietnam nominal GDP forecast, 2009−14 (VNDbn, nominal prices)z
Table 19: Vietnam real GDP, 2004−09 (VNDbn, 2000 prices)
Table 20: Vietnam real GDP forecast, 2009−14 (VNDbn, 2000 prices)
Table 21: Vietnam real GDP, 2004−09 ($bn, 2000 prices)
Table 22: Vietnam real GDP forecast, 2009−14 ($bn, 2000 prices)
Table 23: Vietnam consumer price index, 2004−09 (2000=100)
Table 24: Vietnam consumer price index, 2009−14 (2000=100)
Summary category level: analgesics
CHAPTER 2 DEFINITION
CHAPTER 3 CATEGORY ANALYSIS: ANALGESICS
Value analysis (Vietnamese Dong), 2004−09
Value analysis (Vietnamese Dong), 2009−14
Value analysis (US dollars), 2004−09
Value analysis (US dollars), 2009−14
Company and brand share analysis
Distribution analysis
CHAPTER 4 MACROECONOMIC PROFILE
Macroeconomic Indicators
CHAPTER 5 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Analgesics, Vietnam, value by segment (VNDm), 2004−14
Figure 2: Analgesics, Vietnam, category growth comparison, by value, 2004−14
Figure 3: Analgesics, Vietnam, company share by value (%), 2008−09
Figure 4: Analgesics, Vietnam, distribution channels by value (%), 2008−09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Analgesics category definitions
Table 2: Analgesics distribution channels
Table 3: Analgesics, Vietnam, value by segment (VNDm), 2004−09
Table 4: Analgesics, Vietnam, value forecast by segment (VNDm), 2009−14
Table 5: Analgesics, Vietnam, value by segment ($m), 2004−09
Table 6: Analgesics, Vietnam, value forecast by segment ($m), 2009−14
Table 7: Analgesics, Vietnam, brand share by value (%), 2008−09
Table 8: Analgesics, Vietnam, value by brand (VNDm), 2008−09
Table 9: Analgesics, Vietnam, company share by value (%), 2008−09
Table 10: Analgesics, Vietnam, value by company (VNDm), 2008−09
Table 11: Analgesics, Vietnam, distribution channels by value (%), 2008−09
Table 12: Analgesics, Vietnam, value by distribution channel (VNDm), 2008−09
Table 13: Vietnam population, by age group, 2004−09 (millions)
Table 14: Vietnam population forecast, by age group, 2009−14 (millions)
Table 15: Vietnam population, by gender, 2004−09 (millions)
Table 16: Vietnam population forecast, by gender, 2009−14 (millions)
Table 17: Vietnam nominal GDP, 2004−09 (VNDbn, nominal prices)
Table 18: Vietnam nominal GDP forecast, 2009−14 (VNDbn, nominal prices)z
Table 19: Vietnam real GDP, 2004−09 (VNDbn, 2000 prices)
Table 20: Vietnam real GDP forecast, 2009−14 (VNDbn, 2000 prices)
Table 21: Vietnam real GDP, 2004−09 ($bn, 2000 prices)
Table 22: Vietnam real GDP forecast, 2009−14 ($bn, 2000 prices)
Table 23: Vietnam consumer price index, 2004−09 (2000=100)
Table 24: Vietnam consumer price index, 2009−14 (2000=100)
